The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4

Affiliations

• ¹ School of Cardiovascular and Metabolic Health, Glasgow Cardiovascular Research Centre, University of Glasgow, UK (N.S., M.M.Y.L., P.W.).
• ² Eli Lilly and Company, Indianapolis, IN (G.J.W., R.J.W., K.D., J.W., I.P.).
• ³ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (D.K.M.).
• ⁴ Saint Luke's Hospital of Kansas City, Kansas (M.N.K.).
• ⁵ Division of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, UK (E.R.P.).
• ⁶ Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria (N.P., M.H.).